The Effect of Physical Activity on Decreasing Risk Level
1 other identifier
interventional
22
0 countries
N/A
Brief Summary
Objective: The aim of the first part of this study with two stages is to determine prevalence of CVD risk and the associated variables in individuals aged 40-65 years registered in a Family Health Center (FHC) in city center of Antalya; the aim of the second one is to evaluate the effect of intervention to increase physical activity in individuals with moderate risk of CVD on decreasing the risk level. Methods: Stage 1 and Stage 2 were conducted as cross-sectional and Randomized Controlled Experimental Trial, respectively. In the first stage the CVD risk level was calculated using the HeartScore. In the second stage, 11 individuals with moderate CVD risk (2-\<5%) found in the intervention group participated into a 12-week physical activity program (a moderate walk outdoor, with group 5 days in a week, each lasting for 40 minutes) guided by nurse. CVD brochure and physical activity guide was distributed to 11 individuals in control group within the scope of routine practice of FHCs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2016
CompletedFirst Submitted
Initial submission to the registry
April 2, 2018
CompletedFirst Posted
Study publicly available on registry
April 18, 2018
CompletedApril 18, 2018
April 1, 2018
4 months
April 2, 2018
April 10, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in CVD risk level
"HeartScore® program" was used to determine the CVD risk level in the first stage of the study. In the second part, the risk level was evaluated using HeartScore program for the second time. HeartScore® is a primary prevention tool that provides risk measurement for people who have not had any cardiovascular disease. According to the SCORE score calculated in the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice, individuals are divided into 4 risk categories. Accordingly, if SCORE score is; * ≥%10, very high risk category, * Between ≥%5- \<%10, high risk category * Between ≥%2- \<5, moderate risk category, * \<%1, then they are in the low risk category.
12 week
Secondary Outcomes (2)
Change in Opinions and Experiences about Physical Activity
12 week
Change in Physical activity level
12 week
Study Arms (2)
Intervention group
EXPERIMENTALThe 12-week physical activity program was implemented under the guidance of nurse, in outdoors with the group, 5 days a week with warm up and cooling down for 10 minutes and normal walking tempo at a moderate pace for 30-45 minutes (3-6 km/hour).
Control Group
ACTIVE COMPARATORAs routine practice, a brochure provided from the Public Health Directorate on protection from CVD was delivered to the individuals in the control group.
Interventions
The 12-week physical activity program was implemented under the guidance of nurse, in outdoors with the group, 5 days a week with warm up and cooling down for 10 minutes and normal walking tempo at a moderate pace for 30-45 minutes (3-6 km/hour). Application of WHO Smoking Cessation Algorithm: After fagerström test was applied, the modified smoking cessation algorithm of WHO was applied to the individuals and those who decided to quit smoking were referred to smoking cessation outpatient clinics.
As routine practice, a brochure provided from the Public Health Directorate on protection from CVD was delivered to the individuals in the control group.
Eligibility Criteria
You may qualify if:
- Being aged between 40 and 65 years,
- Not having a problem that could prevent walking activity,
- Being voluntary to participate in the study.
You may not qualify if:
- Having a known and diagnosed CVD, being diagnosed with diabetes (they are evaluated to have a high risk in the European Guidelines on Cardiovascular Disease Prevention and treatment is recommended),
- Having walking disabled,
- Not being voluntary to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebahat Gözüm, Prof
Akdeniz University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2018
First Posted
April 18, 2018
Study Start
June 20, 2016
Primary Completion
October 25, 2016
Study Completion
December 20, 2016
Last Updated
April 18, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share